Meningioma of the skull base: long-term outcome after image-guided stereotactic radiotherapy

Cancer Radiother. 2014 Dec;18(8):730-5. doi: 10.1016/j.canrad.2014.07.159. Epub 2014 Oct 11.

Abstract

Purpose: The purpose of this study was to analyse the feasibility, safety, and long-term efficacy of linear accelerator-based fractionated stereotactic radiotherapy for meningiomas of the skull base. We evaluated the long-term clinical outcome of patients and identified prognostic factors after fractionated stereotactic radiotherapy.

Patients and methods: Between 10/1995 and 03/2009, 136 patients with a median age of 57 years with skull base meningioma received fractionated stereotactic radiotherapy. A total of 34 patients had a grade I meningioma, in 102 cases no histology was obtained (grade 0). Fractionated stereotactic radiotherapy was delivered as primary treatment for 57 patients and postoperatively for 79. The patients received a mean total dose of 56.95 (min/max 32.4/63)Gy.

Results: Median follow-up was 44.9 months. Overall progression-free survival was 96.9% after 3 years, 93.8% after 5 years, and 91.5% after 10 years. Patients with unknown histology showed progression-free survival rates of 100%, 98.7%, and 93.5% at 3, 5, and 10 years and patients with biopsy-proven grade I meningioma showed rates of 100% after 3 years, 91.7% after 5 years and 85.9% after 10 years. Patients with adjuvant radiotherapy showed significantly worse progression-free survival rates than patients who had been treated with primary radiotherapy (P=0.043), progression-free survival rates were independent of tumour size. The most common acute grade I symptoms were headache, fatigue, and local alopecia. The most common chronic grade I symptoms were fatigue and headache.

Conclusions: This large study showed that fractionated stereotactic radiotherapy is an effective and safe treatment modality with high progression-free survival rates for intracranial meningioma. We identified "prior surgery" as significant poor prognostic factor.

Keywords: Base du crâne; Contrôle local; Image-guided intervention; Local control; Meningioma; Méningiome; Radiothérapie guidée par l’image; Radiothérapie stéréotaxique; Skull base; Stereotactic radiotherapy.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Feasibility Studies
  • Female
  • Humans
  • Male
  • Meningioma / radiotherapy*
  • Middle Aged
  • Prognosis
  • Radiosurgery*
  • Retrospective Studies
  • Skull Base Neoplasms / radiotherapy*
  • Surgery, Computer-Assisted*
  • Time Factors
  • Treatment Outcome
  • Young Adult